Literature DB >> 20868323

Can regenerative medicine save Big Pharma’s business model from the patent cliff?

Alexander Denoon, Erik Vollebregt.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20868323     DOI： 10.2217/rme.10.68

Source DB:  PubMed          Journal:  Regen Med        ISSN： 1746-0751            Impact factor:   3.806


× No keyword cloud information.
  3 in total

Review 1.  Regenerative medicine: transforming the drug discovery and development paradigm.

Authors:  Sotirios K Karathanasis
Journal:  Cold Spring Harb Perspect Med       Date:  2014-08-01       Impact factor: 6.915

Review 2.  Reflections on the Future of Pharmaceutical Public-Private Partnerships: From Input to Impact.

Authors:  Remco L A de Vrueh; Daan J A Crommelin
Journal:  Pharm Res       Date:  2017-06-06       Impact factor: 4.200

Review 3.  Patent cliff and strategic switch: exploring strategic design possibilities in the pharmaceutical industry.

Authors:  Chie Hoon Song; Jeung-Whan Han
Journal:  Springerplus       Date:  2016-05-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.